Journal Article (Review Article)

DKFZ-2025-01324

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.

Hennrich, U. (First author)DKFZ* ; Wagner, L.DKFZ* ; Tas, H.DKFZ* ; Kovacs, L.DKFZ* ; Benesova-Schäfer, M. (Last author)DKFZ*

2025
MDPI Basel

This record in other databases:

Please use a persistent id in citations: doi:10.3390/ph18060906

Abstract: Locametz®/Illuccix®/GozellixTM (Novartis AG (Basel, Switzerland) and Telix Pharmaceuticals, Ltd. (Melbourne, Australia), all three [68Ga]Ga-PSMA-11), Pylarify®/Pylclari® (Progenics Pharmaceuticals, Inc. (New York, USA) and Curium PET France SA (Paris, France), both [18F]DCFPyL), Radelumin® (ABX GmbH (Radeberg, Germany), [18F]PSMA-1007), and Posluma® (Blue Earth Diagnostics, Ltd. (Oxford, UK), [18F]rhPSMA-7.3) are four approved PSMA-PET imaging agents that have significantly advanced the diagnosis and management of prostate cancer. These agents offer a new level of precision and accuracy, enabling clinicians to detect prostate cancer with enhanced sensitivity. As a result, they play a critical role in improving detection, staging, and management, ultimately enhancing clinical outcomes for patients. Their use in routine clinical practice is expected to increase diagnostic precision and provide clearer pathways for personalized therapy. This review offers a comprehensive chemical, pharmaceutical, and medicinal overview, discusses comparative studies, and highlights additional highly relevant candidates for prostate cancer detection.

Keyword(s): EMA approval ; FDA approval ; GozellixTM ; Illuccix® ; Locametz® ; PET diagnostics ; PSMA ; Posluma® ; Pylarify® ; Pylclari® ; Radelumin® ; fluorine-18 ; gallium-68 ; prostate cancer

Note: #EA:W630#LA:E270#

---

Contributing Institute(s):

1. Radiopharmazeutika und Präklinische Studien (W630)
2. Translationale Radiotheranostik (E270)

Research Program(s):

1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2025

---

Database coverage:
; ; ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---